Holen Sie sich die Stockscreener-App
117.67
5.41%
-6.73
Handel nachbörslich:
117.00
-0.67
-0.57%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Illumina Inc Aktie (ILMN) Neueste Nachrichten
Exchange Traded Concepts Trims Illumina Stock Holdings - nationaltoday.com
Exchange Traded Concepts LLC Lowers Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
Illumina Inc. stock underperforms Friday when compared to competitors - MarketWatch
RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know - TradingView
Illumina Inc (ILMN) Shares Down 4.86% on Mar 27 - GuruFocus
Vanguard realigns reporting; subsidiaries to report separately (Illumina, ILMN) - Stock Titan
Wealth Enhancement Advisory Services LLC Grows Stock Position in Illumina, Inc. $ILMN - MarketBeat
Illumina Inc. Stock: Dominant Player in Genomic Sequencing Faces Competitive and Regulatory Challeng - AD HOC NEWS
Whole Genome Sequencing Market Key Aspects, Benefits, - openPR.com
DRAGEN v4.5: Expanding Accurate Variant Discovery Across the Entire Genome - Illumina
Illumina Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Argus raises Illumina stock price target to $145 on new products By Investing.com - za.investing.com
Argus raises Illumina stock price target to $145 on new products - Investing.com
Block Trades: Will Illumina Inc benefit from seasonality2026 Macro Impact & Verified Short-Term Trading Plans - baoquankhu1.vn
Illumina Inc. stock navigates Grail divestiture challenges amid biotech sector pressures - AD HOC NEWS
Illumina Inc stock faces headwinds amid Grail divestiture and biotech sector pressures - AD HOC NEWS
Short Squeeze: Will Illumina Inc benefit from seasonality2026 Closing Moves & Weekly Top Gainers Trade List - baoquankhu1.vn
Illumina Inc. stock faces ongoing challenges from Grail divestiture and genomics market pressures - AD HOC NEWS
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina Inc. stock faces headwinds amid Grail divestiture scrutiny and biotech sector slowdown - AD HOC NEWS
Here's why Illumina (ILMN) is a strong growth stock - msn.com
Illumina price gives in to negative pressureForecast today24-03-2026 - Economies.com
US Multiomic Market Set to Boom Rapidly, Witnessing Strong - openPR.com
ILMN Stock Price, Quote & Chart | ILLUMINA INC (NASDAQ:ILMN) - ChartMill
Illumina : CSR Report (2025 illumina france gender pay gap english) - marketscreener.com
Illumina : CSR Report (2025 illumina gender pay gap uk) - marketscreener.com
A $175 Million Move Into Sotera Health Signals Potential Opportunity Amid 21% Stock Drop - The Motley Fool
Prediction Tool Market Poised for Rapid Growth as AI and Genomics - openPR.com
Canaccord reiterates Hold on Illumina stock amid Roche competition - investing.com
Nordea Investment Management AB Boosts Stake in Illumina - National Today
Nordea Investment Management AB Has $124.15 Million Stake in Illumina, Inc. $ILMN - MarketBeat
Healthier Together by BBC Storyworks, the WHO Foundation, and Illumina - Illumina
Illumina Inc. stock faces renewed scrutiny amid Grail divestiture delays and biotech sector headwind - AD HOC NEWS
Illumina Introduces a New AI algorithm PromoterAI: Stock to Gain? - MSN
Swiss Life Asset Management Ltd Purchases 67,772 Shares of Illumina, Inc. $ILMN - MarketBeat
Here’s Why Illumina Could Continue Its 47% Last Year Rally - TIKR.com
Illumina, Inc. (NASDAQ:ILMN) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Illumina and Labcorp Expand Precision Oncology Testing Partnership - Oncodaily
Illumina, Inc. $ILMN Shares Sold by CIBC Private Wealth Group LLC - MarketBeat
Illumina Says China Removed Ban on Importing DNA Sequencers - MSN
ILMN Stock Gains Following Expanded Collaboration With Labcorp - TradingView
In Canada, researching the use of AI to accelerate answers for rare disease - Illumina
DNA Sequencing Market size to hit $108.95 Billion by 2035 | Top - openPR.com
JPMorgan Chase Boosts Illumina Stake by 17.5% - National Today
JPMorgan Chase & Co. Acquires 124,246 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina and Labcorp expand cancer testing collaboration By Investing.com - Investing.com India
Illumina, Labcorp Expand Collaboration to Advance Precision Oncology Testing - marketscreener.com
Illumina and Labcorp expand cancer testing collaboration - Investing.com
Synthetic Biology Market to Reach US$ 67.47 Billion by 2033 | - openPR.com
Life Sciences Tools & Services Stocks Q4 Earnings: Illumina (NASDAQ:ILMN) Firing on All Cylinders - Yahoo Finance
Illumina and Labcorp expand collaboration to broaden access to precision oncology testing - PR Newswire
Investment Report: Is Illumina Inc stock a good dividend stockPortfolio Update Report & Weekly Breakout Watchlists - baoquankhu1.vn
U.S. Bioinformatics Market Is Booming Rapidly with Strong - openPR.com
Labcorp–Illumina cancer pact targets wider access to genomic tests - Stock Titan
Illumina Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Gotham Asset Management LLC Purchases 144,475 Shares of Illumina, Inc. $ILMN - MarketBeat
How Illumina’s Genomics Insurance Push And Multiomic Alliance Expansion At Illumina (ILMN) Has Changed Its Investment Story - simplywall.st
Illumina Adds Activist to Board, Names Former FDA Chief as Chair - MSN
Illumina partners with Veritas Genetics to advance preventive genomics - National Today
Illumina Stock: Here’s Why Numbers Suggest a 63% Upside - TIKR.com
Illumina partners with Veritas to offer genome sequencing via insurers - Investing.com
Illumina advances preventive genomics through strategic consortium with Veritas Genetics - PR Newswire
Illumina, Inc. $ILMN Shares Sold by Ion Asset Management Ltd. - MarketBeat
Bamco Inc. NY Sells 39,378 Shares of Illumina, Inc. $ILMN - National Today
Illumina, Inc. $ILMN Stake Lessened by Cannell & Spears LLC - MarketBeat
Illumina, Inc. $ILMN Shares Sold by Casdin Capital LLC - MarketBeat
1.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):